by telrheum | Mar 31, 2024 | Biologic Therapy, Magnetic Resonance Imaging, Psoriatic Arthritis
The article discusses a study on how tumor necrosis factor-alpha (TNFα) inhibition, a treatment for psoriatic arthritis (PsA), affects pain processing in the brain, using functional magnetic resonance imaging (fMRI). The study included 6 PsA patients, some new to...
by telrheum | Mar 31, 2024 | Psoriasis, Psoriatic Arthritis, Spondyloarthritis
Hemay005 is an experimental drug being tested for its ability to treat chronic inflammatory diseases like psoriasis by inhibiting a specific enzyme, PDE4, which plays a key role in the inflammation process. The drug aims to reduce the activity of T lymphocytes and...
by telrheum | Mar 30, 2024 | Radiology, Magnetic Resonance Imaging, Spondyloarthritis
In this study, researchers focused on leveraging deep learning technology to enhance the diagnosis of axial spondyloarthritis (SpA), specifically by detecting active spinal inflammation through MRI scans. A total of 330 patients diagnosed with axial SpA were involved...
by telrheum | Mar 30, 2024 | Biologic Therapy, Systemic Sclerosis
The article reports on a study where three patients with severe diffuse Systemic Sclerosis (SSc), a form of autoimmune disease, underwent a treatment involving CD19-targeting CAR-T cells. These cells are a type of therapy that modifies the patient’s T-cells to attack...
by telrheum | Mar 30, 2024 | Autoimmune Diseases, Infections, Lymphoma, Sjögren’s Syndrome
The article “35 Years Follow-up of Primary Sjögren’s Disease: A Single Center Study” by Lorena Montano-Tapia and colleagues is a long-term study of patients with Primary Sjögren’s Syndrome (pSS), an autoimmune disease affecting exocrine glands. Conducted at the...